No Data
No Data
Sinopharm Group Schedules Key Financial Review Meeting
Sinopharm (01099.HK) plans to hold a board of directors meeting on August 23 to approve the interim performance.
Sinopharm (01099.HK) announced that a board of directors meeting will be held on August 23, 2024 (Friday) to consider and approve (including) unaudited interim results of the company and its subsidiaries for the six months ending June 30, 2024.
SINOPHARM: NOTICE OF BOARD MEETING
Express News | China's Sinopharm: Has No Business Dealings With Shanxi Aorui Biomaterials
Tracking of Hong Kong stock concepts | The Medical Insurance Bureau has announced the new medical insurance catalog. Institutions believe that the golden opportunity to increase the allocation of the pharmaceutical sector has already opened (including con
The National Medical Insurance Bureau has conducted preliminary reviews on 440 pharmaceuticals for this year's medical insurance catalog, which is an increase from last year.
CICC: The pharmaceutical sector has entered a value investment range, focusing on the domestic innovative drug industry chain and going overseas.
China International Capital Corporation released a research report stating that after three years of systematic adjustment, the pharmaceutical sector has entered the range of value investment.
No Data